Efficacy and Safety of Sacubitril/Valsartan in African American Patients With Heart Failure With Reduced Ejection Fraction

Enrolling by invitationOBSERVATIONAL
Enrollment

352

Participants

Timeline

Start Date

August 13, 2020

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Heart Failure
Interventions
DRUG

sacubitril/valsartan

Sacubitril belongs to a class of drugs called neprilysin inhibitors and valsartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). They work by relaxing blood vessels so that blood can flow more easily, which makes it easier for your heart to pump blood to your body.

Trial Locations (1)

75203

Methodist Dallas Medical Center Pharmacy, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER